期刊文献+

Exendin-4对2型糖尿病大鼠肾组织MMP-9与TIMP-1表达的影响 被引量:1

Effects of exendin-4 on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in renal tissue of type 2 diabetic rats
原文传递
导出
摘要 目的:观察Exendin-4对2型糖尿病大鼠肾组织基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶组织抑制物-1(TIMP-1)表达的影响.方法:采用高糖高脂饮食结合小剂量链脲佐菌素(STZ)腹腔注射的方法,建立2型糖尿病大鼠模型.将成模大鼠随机分为糖尿病组,exendin-4低、中、高剂量组,并设立正常对照组.给药6wk后,采用免疫组化方法检测各组大鼠肾组织中MMP-9,TIMP-1的蛋白表达.结果:糖尿病组MMP-9,TIMP-1的表达较正常对照组明显增强(P<0.01);exendin-4各组较糖尿病组MMP-9,TIMP-1表达减弱(P均<0.01).结论:Exendin-4对2型糖尿病大鼠有一定的肾脏保护作用,其机制可能部分是通过下调2型糖尿病大鼠肾组织MMP-9和TIMP-1的表达来实现的. AIM:To observe the effects of exendin-4 on the expression of matrix metalloproteinase-9(MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) in the renal tissue of type 2 diabetic rats. METHODS:The rat model of type 2 diabetes mellitus was set up by a combination of high fat diat and low dose streptozotocin(STZ). The diabetic rats were randomly divided into 4 groups :diabetes mellitus group(DM group),low dose of exendin-4 group(EL group),middle dose of exendin-4 group(EM group),high dose of exendin-4 group(EH group). Normal control group (NC group) was also established. After 6 weeks, the expression of MMP-9 and TIMP-1 in renal tissue was measured by immunohistochemistry. RESULTS: The expression of MMP-9 and TIMP-1 in DM group was higher than that in NC group(P 〈0.01 ) , while the expression of MMP-9 and TIMP-1 in all doses of exendin-4 groups was lower than that in DM group( P 〈0.01 ). CONCLUSION: Exendin-4 has some renoprotective effect on type 2 diabetic rats, partly through down-regulating the expression of MMP-9 and TIMP-1.
出处 《第四军医大学学报》 北大核心 2009年第21期2306-2309,共4页 Journal of the Fourth Military Medical University
关键词 EXENDIN-4 2型糖尿病 糖尿病肾病 基质金属蛋白酶-9 基质金属蛋白酶组织抑制物-1 exendin-4 type 2 diabetes mellitus diabetic nephropathy matrix metalloproteinase-9 tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献7

  • 1Goke R, Fehmann HC, Linn T,et al. Exendin-4 is a high potency agonist and truncated exendin-( 9-39 )-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting- cells [J ]. J Biol Chem, 1993,268 ( 26 ) : 19650 - 19655.
  • 2Gutzwiller JP, Tschopp S, Bock A, et al. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men[J]. J Clin Endocrinol Metab, 2004, 89(6) : 3055 -3061.
  • 3Park CW, Kim HW, Ko SH, et al. Long-term treatment of glucagon-like peptide-1 analog exendin4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice [ J]. J Am Soc Nephrol,2007,18 : 1227 - 1238.
  • 4Schaefer L, Han X, August C, et al. Differential regulation of glomerular gelatinase B ( MMP-9 ) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats [ J ]. Diabetologia, 1997, 40(9) :1035 - 1043.
  • 5Tashiro K, Koyanagi I, Ohara I, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy [ J ]. J Clin Lab Anal, 2004, 18 ( 3 ) : 206 -210.
  • 6Nielsen LL, Young AA, Parkes DG. Pharmacology of exenatide (synthetic exendin-4) : A potential therapeutic for improved glycemic control of type 2 diabetes [ J ]. Regul Pept, 2004, 117 ( 2 ) : 77 - 88.
  • 7Brubaker PL, Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors [ J]. Receptors Channels, 2002, 8 : 179 - 188.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部